Brief: Allergy Therapeutics's Phase I VLP Peanut Protect Trial Progress

Allergy Therapeutics

26/09/2023 07:26

Sept 26 (Reuters) - Allergy Therapeutics PLC  AGY.L :
    * ALLERGY THERAPEUTICS  - PHASE I VLP PEANUT PROTECT TRIAL
PROGRESS
    * ALLERGY THERAPEUTICS PLC - APPROVAL GRANTED TO COMMENCE
ESCALATING SUBCUTANEOUS DOSING IN PEANUT ALLERGIC PATIENTS
    * ALLERGY THERAPEUTICS PLC - SAFETY REVIEW COMMITTEE
APPROVES
FURTHER DOSE ESCALATION IN SUBSEQUENT COHORTS
    * ALLERGY THERAPEUTICS PLC - FULL RESULTS FROM TRIAL ARE
EXPECTED
IN 2024

Source text for Eikon:  ID:nRSZ5954Na 
Further company coverage:  AGY.L 

 ((Reuters.Briefs@thomsonreuters.com;))